RECRUITING

Prevent Cancer- Greenville

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Prevent Cancer-Greenville was created to provide individuals with the opportunity to have their risk of developing cancer studied. Some individuals may be at a higher risk due to their personal lifestyle, family history and/or exposures. If subjects are found to be at high risk for developing a disease, they will be sent to a healthcare provider for further care.

Official Title

Prevent Cancer-Greenville: A Center for Cancer Prevention and Wellness Research Project

Quick Facts

Study Start:2018-11-08
Study Completion:2029-11-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04947098

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years or older
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Patricia Wilson, MSN Ed. OCN ONNCG
CONTACT
864-455-4897
ccpw@prismahealth.org
Rachel Zeigler, MS
CONTACT
864-455-6251
rachel.zeigler@prismahealth.org

Principal Investigator

Joe Stephenson, MD
PRINCIPAL_INVESTIGATOR
Prisma Health-Upstate

Study Locations (Sites)

Prisma Health-Upstate
Greenville, South Carolina, 29605
United States

Collaborators and Investigators

Sponsor: Prisma Health-Upstate

  • Joe Stephenson, MD, PRINCIPAL_INVESTIGATOR, Prisma Health-Upstate

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-11-08
Study Completion Date2029-11-08

Study Record Updates

Study Start Date2018-11-08
Study Completion Date2029-11-08

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer
  • High-Risk Cancer